Apimeds Pharmaceuticals Q1 EPS $(2.26) Down From $(0.50) YoY

Benzinga Newsdesk www.benzinga.com Negative 96.3%

Neg 96.3% Neu 0% Pos 0%

Apimeds Pharmaceuticals (AMEX:APUS) reported quarterly losses of $(2.26) per share. This is a 352 percent decrease over losses of $(0.50) per share from the same period last year.